Increased cortical mGlu5 and CB1 forebrain binding has been recently reported in subjects with a PTSD diagnosis, suggesting clinical relevance of manipulations targeting mGlu5 and/or CB1 receptors23,55. This evidence concerns the gene CNR1 and post-traumatic stress disorder.